Additional Coverage:
HHS Halts mRNA Vaccine Development, Sparks Controversy
In a controversial move, the US Department of Health and Human Services (HHS) announced Tuesday it will discontinue funding for mRNA vaccine development through the Biomedical Advanced Research and Development Authority (BARDA). HHS Secretary Robert F.
Kennedy Jr. stated that 22 mRNA vaccine projects will be terminated, claiming the vaccines “fail to protect effectively against upper respiratory infections.” This assertion contradicts evidence demonstrating their effectiveness against severe illness and death from Covid-19, and their potential against influenza.
While some existing contracts will be fulfilled, no new mRNA research will be pursued.
Kennedy stated the decision was based on a review of scientific evidence and expert consultation. HHS will prioritize vaccine platforms with purportedly “stronger safety records” and “transparent data practices,” such as whole-virus vaccines and novel platforms. The agency criticized mRNA technology, despite its rapid development and proven effectiveness during the Covid-19 pandemic.
This decision has drawn sharp criticism from leading medical experts. Dr.
Peter Hotez, director of the Center for Vaccine Development at Texas Children’s Hospital, condemned the move, arguing it will undermine national biosecurity and promote pseudoscience. He emphasized the advantages of mRNA technology, particularly for pandemic response and cancer research, and warned that states will be left to their own devices for biomedical innovation.
The HHS announcement detailed the cancellation of several key mRNA projects, including Moderna/UTMB’s avian flu vaccine and contracts with Emory University and Tiba Biotech. Collaborations with the Department of Defense involving nucleic acid-based vaccines will also be restructured, impacting projects with AAHI, AstraZeneca, and HDT Bio.
The total value of the affected projects is estimated at $500 million. HHS clarified that other mRNA applications within the department remain unaffected.
Moderna confirmed the prior cancellation of its pandemic flu contract but stated no other cancellations were known. Gritstone reported it had ceased operations, and AstraZeneca declined comment. Other impacted organizations were contacted for a response.
Renowned vaccine expert Dr. Paul Offit criticized Kennedy’s decision as contradicting scientific data, highlighting the proven safety and efficacy of mRNA vaccines. He expressed concern that this policy, based on “false statements,” increases national risk for future pandemics.
Dr. Jake Scott, an infectious diseases physician who witnessed the impact of mRNA vaccines firsthand during the Covid-19 pandemic, expressed sadness and dismay at the announcement. He emphasized the profound positive impact of mRNA vaccines in protecting billions from severe illness and death.